ReviewCurrent urology reports2026
Advancements in the Treatment and Management of Voiding Dysfunction in Individuals with Spina Bifida.
Review in Current urology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis manuscript aims to provide an overview of the pathophysiology of voiding dysfunction, management goals, and treatment options for individuals with spina bifida in order to better assist providers caring for these patients and their families. RECENT
findingsRecent studies have demonstrated efficacy and safety of beta-3 agonists and onabotulinum toxin A as noninvasive options for management of neurogenic lower urinary tract dysfunction. Studies focusing on patient reported outcomes and health-related quality of life have raised greater awareness of patient goals and socio-environmental factors in the counseling of different treatment options. This review highlights the latest research on the management of voiding dysfunction in patients living with spina bifida. Better understanding of pathophysiology and new developments in non-invasive treatment options have substantially improved long-term durability and outlook for these patients. Future research should aim to identify patient and family goals to better manage expectations and quality of life for this lifelong condition.
Indexed as
Identifiers
41975082What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.